This article explains what clinicians and expectant mothers mean when they say paracetamol is “safe in pregnancy”. It clarifies that safety is relative: paracetamol is generally recommended as the first-line option for fever and mild-to-moderate pain because evidence from trials and guideline reviews shows a favorable risk–benefit profile compared with alternatives, but observational studies have suggested possible small associations with neurodevelopmental outcomes (eg, ADHD, ASD) that remain uncertain and may reflect confounding. Practical guidance is summarised: use the lowest effective dose for the shortest necessary time, avoid routine long-term or high-dose use, seek personalised advice from a healthcare professional (especially for repeated or high-dose use), and consider non-drug measures where appropriate. The piece emphasises evidence limitations, the importance of shared decision-making, and following national maternity-care guidance for expat and local patients alike.